These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
23. Kinetics and disposition of hexarelin, a peptidic growth hormone secretagogue, in rats. Roumi M; Marleau S; du Souich P; Maggi T; Deghenghi R; Ong H Drug Metab Dispos; 2000 Jan; 28(1):44-50. PubMed ID: 10611139 [TBL] [Abstract][Full Text] [Related]
24. Distribution and excretion of methamphetamine and its metabolites in rats. III. Time-course of concentrations in blood and bile, and distribution after intravenous administration. Sakai T; Niwaguchi T; Kimura R; Murata T Xenobiotica; 1985 Jan; 15(1):31-40. PubMed ID: 3984382 [TBL] [Abstract][Full Text] [Related]
25. Synthesis of optically active 2-(4-(2-thienylcarbonyl)-phenyl)propionic acid labeled with deuterium. Mori Y; Shibata M; Toyoshi K; Baba S; Horie M; Oshika Y; Ohira K Radioisotopes; 1981 Nov; 30(11):590-5. PubMed ID: 7335896 [TBL] [Abstract][Full Text] [Related]
26. The absorption, tissue distribution and excretion of di-n-octyltin dichloride in rats. Penninks AH; Hilgers L; Seinen W Toxicology; 1987 Apr; 44(1):107-20. PubMed ID: 3564046 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the rat. Stüben J; Port R; Bertram B; Bollow U; Hull WE; Schaper M; Pohl J; Wiessler M Cancer Chemother Pharmacol; 1996; 38(4):355-65. PubMed ID: 8674159 [TBL] [Abstract][Full Text] [Related]
28. Disposition of moxalactam and N-methyltetrazolethiol in rats and monkeys. Mizojiri K; Norikura R; Takashima A; Tanaka H; Yoshimori T; Inazawa K; Yukawa T; Okabe H; Sugeno K Antimicrob Agents Chemother; 1987 Aug; 31(8):1169-76. PubMed ID: 3631941 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species. Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298 [TBL] [Abstract][Full Text] [Related]
31. [Pharmacokinetics and disposition of a new anticancer antibiotic (2''R)-4'-O-tetrahydropyranyladriamycin in rats. Distribution and excretion after a single administration]. Tone H; Iguchi H; Fujigaki M; Nishio M; Esumi Y; Takaichi M; Tsutsumi S; Yokoshima T Jpn J Antibiot; 1986 Feb; 39(2):612-28. PubMed ID: 3712761 [TBL] [Abstract][Full Text] [Related]
32. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats. Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071 [TBL] [Abstract][Full Text] [Related]
33. Bioavailability and corneal anti-inflammatory effect of topical suprofen. Leibowitz HM; Ryan WJ; Kupferman A; DeSantis L Invest Ophthalmol Vis Sci; 1986 Apr; 27(4):628-31. PubMed ID: 3957583 [TBL] [Abstract][Full Text] [Related]
34. Metabolism and disposition of 2,3,7,8-tetrachlorodibenzo-p-dioxin in guinea pigs. Olson JR Toxicol Appl Pharmacol; 1986 Sep; 85(2):263-73. PubMed ID: 3764914 [TBL] [Abstract][Full Text] [Related]
35. Metabolism of dibucaine. II. Disposition and metabolism of dibucaine in rats. Igarashi K; Kasuya F; Fukui M J Pharmacobiodyn; 1989 Sep; 12(9):523-9. PubMed ID: 2614642 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic properties of the antimuscarinic drug [3H]-hexahydro-sila-difenidol in the rat. Rettenmayr NM; Rodrigues de Miranda JF; Rijntjes NV; Russel FG; van Ginneken CA; Strohmann C; Tacke R; Lambrecht G; Mutschler E Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):146-52. PubMed ID: 2234099 [TBL] [Abstract][Full Text] [Related]
37. Studies on the metabolism and toxicity of dinitrotoluenes--on the absorption and excretion of tritium-labelled 2,4-dinitrotoluene (3H-2, 4-DNT) in the rat. Mori M; Naruse Y; Kozuka H Radioisotopes; 1978 Dec; 27(12):715-9. PubMed ID: 746173 [TBL] [Abstract][Full Text] [Related]
38. The disposition and pharmacokinetics of ketoconazole in the rat. Remmel RP; Amoh K; Abdel-Monem MM Drug Metab Dispos; 1987; 15(6):735-9. PubMed ID: 2893696 [TBL] [Abstract][Full Text] [Related]
39. [Metabolic fate of bufalin in rats]. Toma S; Hirai Y; Sugimoto C; Shoji M; Oguni Y; Morishita S; Ito C; Horie M Yakugaku Zasshi; 1991 Nov; 111(11):676-86. PubMed ID: 1783982 [TBL] [Abstract][Full Text] [Related]
40. [Distribution, metabolism and excretion of 14C-MT-141 in rats. I. Distribution, metabolism and excretion after single intravenous administration in male rats]. Komiya I; Ishizuka T; Nishio M; Murata S; Esumi Y; Washino T; Matsunaga K; Mitsugi K; Yokoshima T Jpn J Antibiot; 1984 May; 37(5):927-37. PubMed ID: 6434764 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]